Showing results (31-40 of 155) with videos related to
Sort By:
Pageof 16
Computers in Biology and Medicine|February 25, 2019
Acceleration of spleen segmentation with end-to-end deep learning method and automated pipelineHyeonsoo Moon, Yuankai Huo, Richard G Abramson, et al.British Journal of Haematology|February 22, 2017
A phase 2 study of simtuzumab in patients with primary, post-polycythaemia vera or post-essential thrombocythaemia myelofibrosisSrdan Verstovsek, Michael R Savona, Ruben A Mesa, et al.IEEE Transactions on Medical Imaging|October 19, 2018
SynSeg-Net: Synthetic Segmentation Without Target Modality Ground TruthYuankai Huo, Zhoubing Xu, Hyeonsoo Moon, et al.Cancer Immunology Research|March 12, 2016
Myelodysplastic Syndrome Revealed by Systems Immunology in a Melanoma Patient Undergoing Anti-PD-1 TherapyAllison R Greenplate, Douglas B Johnson, Mikael Roussel, et al.Journal of Medical Imaging (Bellingham, Wash.)|February 26, 2021
Validation and estimation of spleen volume via computer-assisted segmentation on clinically acquired CT scansYiyuan Yang, Yucheng Tang, Riqiang Gao, et al.Biorxiv : the Preprint Server for Biology|April 25, 2024
Repair of leukemia-associated single nucleotide variants via interallelic gene conversionAlexander James Silver, Donovan J Brown, Sarah D Olmstead, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 31, 2019
A Phase Ib/II Study of Oprozomib in Patients with Advanced Multiple Myeloma and Waldenström MacroglobulinemiaIrene M Ghobrial, Ravi Vij, David Siegel, et al.Gene|April 13, 2025
Interallelic gene conversion of leukemia-associated single nucleotide variantsAlexander J Silver, Donovan J Brown, Sarah D Olmstead, et al.Cell Host & Microbe|March 16, 2011
HIV-1 utilizes the CXCR4 chemokine receptor to infect multipotent hematopoietic stem and progenitor cellsChristoph C Carter, Lucy A McNamara, Adewunmi Onafuwa-Nuga, et al.Clinical Lymphoma, Myeloma & Leukemia|March 9, 2022
A Phase 1/2 Study of the Oral Janus Kinase 1 Inhibitors INCB052793 and Itacitinib Alone or in Combination With Standard Therapies for Advanced Hematologic MalignanciesAmer M Zeidan, Rachel J Cook, Rodolfo Bordoni, et al.Pageof 16